Fig. 3From: Neuroinflammation-associated miR-106a-5p serves as a biomarker for the diagnosis and prognosis of acute cerebral infarctionSerum high miR-106a-5p levels predicts poor prognosis in ACI patients. Compared with the favorable group, the expression level of miR-106a-5p was significantly increased in the unfavorable group. ***P < 0.001Back to article page